MIAMI, April 6, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, P.A. advised Israel-based Entera Bio Ltd. (Nasdaq: ENTX), a clinical-stage biotechnology company focused on the development of oral peptide and protein replacement therapies, in a $10 million private placement led by funds affiliated with private investment firm BVF Partners L.P.
Read more at prnewswire.com
Greenberg Traurig Represents Israel-based Entera Bio in $10M Private Placement Led by BVF Partners
Provided By PR Newswire – Last update: